Featured Products & Services
-
Broad Scale Oligonucleotide Synthesizer For Better Production Outcomes
2/9/2023
OligoProcess covers a range of 10 to 1800 mmol and is suitable for quantities required in clinical phases and commercial production.
-
Automated, Single-Use System For Clinical And Commercial LNP Production
7/21/2023
The NanoAssemblr® commercial formulation system is an automated, single-use system for the clinical and commercial production of lipid nanoparticles (LNPs) under cGMP conditions. Designed for efficient changeover and robust manufacturing processes, the system enables operational flexibility and standardized manufacturing of genomic medicines.
-
Patient Recruitment And Site Selection
12/20/2022
Novotech relies on years of experience, in-country knowledge, and real-life big data to identify and propose the best-performing sites. Uncover the possibilities for your next study.
-
Plasmid DNA Production
6/23/2022
Integrated manufacturing supporting cell and gene therapies.
The critical genetic foundation for advanced therapies
Plasmid DNA is a critical raw material for advanced therapies and mRNA synthesis, supporting their transfection to enable rapid advancement of the therapeutic product. Center for Breakthrough Medicines (CBM) offers capacity dedicated to the development and manufacture of high quality plasmid DNA and other nucleic acids.
-
Excellence For Cell And Gene Therapy Manufacturing
6/4/2025
Unlock the potential of advanced therapies with dedicated partnership and tailored manufacturing solutions, ensuring quality and efficiency from discovery through to delivery for next-generation treatments.
-
UNICORN™ Control Chromatography System
6/5/2024
UNICORN™ control software offers real-time control of protein purification unit operations (column packing and chromatography) from laboratory bench, through development, to full-scale production. UNICORN™ control system meets the needs of full-scale production with manufacturing systems while maintaining the flexibility needed for method and process development with the range of systems in the ÄKTA™ family.
-
Chromatography Membrane For Single-Use Per Batch Biomolecule Purification
9/21/2020
For single-use per batch biomolecule purification
A high capacity, high throughput strong anion exchange chromatography membrane designed for single-use per batch biomolecule purification. The unique Natrix® Q membrane contains a high density of quaternary amine ligands that are directly polymerized within the porous membrane scaffold.
-
Bionanoparticle Technology
4/24/2023
Nanoform’s proprietary bionanoparticle technology can deliver large-molecule drug particles as small as 50 nm while retaining biological activity. This can not only enable more patient-friendly approaches to drug delivery, but also potentially higher loads of active ingredients.
-
ÄKTA oligosynt™ Oligonucleotide Synthesizer
3/28/2022
The ÄKTA oligosynt™ oligonucleotide synthesizer is a compact, fully automated oligonucleotide synthesizer built for research and process development laboratories. The system supports a robust and easily scalable oligonucleotide synthesis process and transfer to larger oligonucleotide synthesizers with high yield and quality.
-
Comprehensive mRNA Solutions
1/31/2025
Curia’s combined expertise and a proven track record of success in key scientific disciplines including molecular biology, protein production and analysis, enzymes, nucleosides and lipids is the foundation of our mRNA solution. Partner with us and harness our ability to provide high-quality constructs through in-house research and analysis capabilities that enable accelerated timelines for delivery.